TG-1 * Transgallaxys Forum 1

Advanced search  

News:



We are Allaxys
We moved our news front to http://www.allaxys.com

The Forum 1 on Transgallaxys.com is only a backup archive!

Twin Update 8.5.2023

Because of their sabotage the Net nazis
"Amazon Data Services Nova", Ashburn, United States
"Amazon Data Services" Singapore
"Amazon Data Services" Japan
ARE BLOCKED

Pages: [1]

Author Topic: OH SHIT! 'Evidence-Based Human Homeopathy and Veterinary Homeopathy'  (Read 173 times)

Pangwall

  • Jr. Member
  • *
  • Posts: 1100

Für die üblichen Verdächtigen...


https://www.mdpi.com/2076-2615/12/16/2097

[*quote*]
Journals Animals Volume 12 Issue 16
10.3390/ani12162097
Article has an altmetric score of 21 Altmetric

Reply published on 17 August 2022, see Animals 2022, 12(16), 2098.
Comment of Animals 2021, 11(12), 3356.

Evidence-Based Human Homeopathy and Veterinary Homeopathy. Comment on Bergh et al. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356
by Petra Weiermayer
1,*, Michael Frass
2, Thomas Peinbauer
3, Liesbeth Ellinger
4 and Edward De Beukelaer
5
1
Veterinary Practice Dr. Weiermayer, 1130 Vienna, Austria
2
Scientific Society for Homeopathy, 06366 Koethen, Germany
3
Medical Faculty, Johannes Kepler University, 4040 Linz, Austria
4
Centaurea, 7312 Apeldoorn, The Netherlands
5
Riverside Veterinary Centre, Marlborough SN8 2AG, UK
*
Author to whom correspondence should be addressed.
Animals 2022, 12(16), 2097; https://doi.org/10.3390/ani12162097
Received: 31 December 2021 / Revised: 13 April 2022 / Accepted: 9 June 2022 / Published: 17 August 2022
(This article belongs to the Collection Veterinary Rehabilitation and Sports Medicine)
Download Versions Notes

Simple Summary
According to the simile principle (Similia similibus curentur, or ‘Let like be cured by like’), classical (=individualized) homeopathic therapy is based on the individual and not on the indication. Based on the following three facts, the discussion of the evidence in human and veterinary homeopathy lays the foundations for a comprehensive presentation of the evidence on homeopathy: (a) homeopathic medicinal products without indication are 100% identical with regard to production, quality, safety, and principles of application, regardless of whether they are used in animals or humans; (b) if the simile principle is adhered to that classical (=individualized) homeopathic therapy is based on the individual and not on the indication; and (c) if the proof of effectiveness of individualized homeopathy in one or more indications is available, the logical consequence seems to be that it can be concluded that it is effective in other indications. When criteria for evidence-based medicine for design, conduction, documentation, and rating of studies in homeopathy are considered, effects on all quality levels according to Cochrane criteria are recognizable, especially for individualized homeopathy, even in methodologically high-quality studies. In view of One Health and of the demands of the European Green Deal (Farm2Fork Strategy) and the EU Organic Regulation 2018/848, the application of homeopathy in the sense of integrative veterinary medicine (a combination of patient-oriented conventional and complementary veterinary medicine) and the integration of complementary medicine including homeopathy at the universities seems a necessary consequence and requirement in the interests of the patient.
Abstract
(1) Background: Classical (=individualized) homeopathic therapy is based on the individual and not on the indication. (2) Methods: The prerequisite for conducting methodologically high-quality studies on indvidualized homeopathy is that the principles of homeopathy are considered, since the selection of the simile (the individually appropriate homeopathic medicinal product) is decisive for the effectiveness of the homeopathic treatment, because only an application lege artis can be effective for the respective patient. Apart from this, criteria for evidence-based medicine must be considered for design, conduction, documentation, and rating of studies in homeopathy. (3) Results: When criteria for evidence-based medicine for design, conduction, documentation, and rating of studies in homeopathy are considered, effects on all quality levels according to Cochrane criteria are recognizable, especially for individualized homeopathy, even in the methodologically high-quality studies. (4) Conclusions: Based on the following three facts, the discussion of the evidence in human and veterinary homeopathy lays the foundations for a comprehensive presentation of the evidence on homeopathy: (a) homeopathic medicinal products without indication are 100% identical with regard to production, quality, safety, and principles of application, regardless of whether they are used in animals or humans; (b) if the simile principle (Similia similibus curentur, or ‘Let like be cured by like’) is adhered to that classical (=individualized) homeopathic therapy is based on the individual and not on the indication; and (c) if the proof of effectiveness of individualized homeopathy in one or more indications is available, the logical consequence seems to be that it can be concluded that it is effective in other indications. In view of One Health and of the demands of the European Green Deal (Farm2Fork Strategy) and the EU Organic Regulation 2018/848, the application of homeopathy in the sense of integrative veterinary medicine and the integration of complementary medicine including homeopathy at universities seems a necessary consequence and requirement in the interests of the patient, which is already expressed in the American consensus guidelines for an integrative veterinary medicine curriculum and is legally anchored in Switzerland by the Medical Professions Act for university teaching and research.
Keywords:
evidence; homeopathy; veterinary homeopathy; One Health; antimicrobial resistance

1. Introduction
The way homeopathy has been represented over the past years as well as in the article ‘A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”’, a systematic review on published papers [1], clearly shows the need of in-depth knowledge of integrative medicine (a combination of patient-oriented conventional and complementary medicine). In the US, integrative medicine is a self-evident part of the curriculum of the veterinary schools and of the top medical schools, from Harvard to Stanford. In Europe, there is hardly any academic integration and very few public or university funds available for research into integrative medicine, with the exception of Switzerland. Especially, in view of the global threat posed by antibiotic resistance, the integration of complementary medicine including homeopathy at universities is a necessary consequence and requirement in the interests of the patient. Fortunately, it is already expressed in the American consensus guidelines for an integrative veterinary medicine curriculum and is legally anchored in Switzerland by the Medical Professions Act for university teaching and research [2,3,4].
The German physician Dr. Samuel Hahnemann (1755–1843) developed the medical system of individualized, so-called classical homeopathy or single-substance homeopathy. The treatment is based on the law of similars—Similia similibus curentur, or ‘Let like be cured by like’. The patient’s individual symptoms lead to the simile, i.e., the homeopathic medicinal product, the symptoms of which, generated in healthy individuals, best reflect the patient’s symptoms [5]. In accordance with the regulations of the European Pharmacopoeia or of the Homeopathic Pharmacopoeia, homeopathic medicinal products are produced in a standardized manner [6,7].
2. Materials and Methods
Since the selection of the simile is decisive for the effectiveness of the homeopathic treatment, for conducting methodologically high-quality studies on individualized homeopathy it is the prerequisite that the principles of homeopathy are considered. Only an application lege artis can be effective for the respective patient. It is unlikely that the desired effectiveness will follow, if the individually appropriate homeopathic medicinal product, the simile, is not selected by appropriately trained and experienced homeopathic doctors/veterinarians according to the basic homeopathic principles [4]. A study of 2008 already confirmed that, for the successful application of individualized homeopathy, the basic principles—i.e., individualized selection of a homeopathic medicinal product according to the principle of similarity—must be taken into account [8]. Research in individualized homeopathy that does not respect the essential basic principles of individualized homeopathy prescribing will inevitably lead to negative study outcomes [4,9]. Apart from this, criteria for evidence-based medicine must be considered for design, conduction, documentation, and rating of studies in homeopathy.
3. Results
Up to 2014, five of the six meta-analyses on various indications concluded that the effectiveness of homeopathic therapy differs from that of placebo [10,11,12,13,14]. Of a total of 131 original articles, 13 RCTs with minimal risk of bias were identified in the review program from 2014, 2017, 2018, and 2019 [14,15,16,17]. Ten of these RCTs testing homeopathy in comparison to placebo resulted in a mean OR of 1.68 (CI = 1.25–2.24; p < 0.001), i.e., a statistical significance for the effectiveness of homeopathy compared with placebo. Such ‘effect size’ seems comparable with, for example, sumatriptan for migraine, fluoxetine for major depressive disorder, and cholinesterase inhibitors for dementia [14]. Five of the 13 RCTs with minimal risk of bias also showed high reliable evidence [18,19,20,21,22]. Especially for individualized homeopathy, effects on all quality levels according to Cochrane criteria are recognizable, even in the methodologically high-quality studies, when criteria for evidence-based medicine for design, conduction, documentation, and rating of studies in homeopathy are applied, e.g., all high-quality trials on homeopathy are considered for rating [4]. As the authors of the article ‘A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”’ exclude farm animals from the systematic review, they exclude 16 out of 18 RCTs on veterinary homeopathy which were analyzed by the meta-analysis of 2015 [23]. However, further high-quality studies are also necessary in human and veterinary homeopathy, as in the majority of the fields of human and veterinary medicine. For veterinary homeopathy, the review of 2014 and the meta-analysis of 2015 showed evidence of the effectiveness of veterinary homeopathy compared to placebo (p = 0.01 for n = 15, pooled OR = 1.69 (CI = 1.12–2.56), p = 0.02 for n = 2, pooled OR = 2.62 (CI = 1.13–6.05)) [23,24]. In addition to studies to demonstrate the effectiveness of homeopathy in infections, data from health care research, so-called ‘real world data’, show the potential for a significant reduction in the use of antibiotics through homeopathic treatments [4].
4. Discussion
A 2007 Cochrane review of systematic reviews of predominantly conventional therapies revealed that 96% of all systematic reviews call for more methodologically high-quality research [25]. Forty-nine percent of these publications present results that do not allow any conclusions to be drawn about the benefit/harmfulness of the examined intervention. According to this review, 7% of all medical procedures are actually harmful. Only 1.38% of conventional therapies are definitely effective, 43% are classed as effective, but the studies show methodological deficiencies. Based on the results of the meta-analyses of 2014, 2015, 2017, 2018, and 2019, homeopathy should be classified provisionally in the group of therapies (conventional 44%: 1.38% plus 43%), which are effective but need further research [14,15,16,17,25]. When criteria for evidence-based medicine for design, conduction, documentation, and rating of studies in homeopathy are considered, e.g., all high-quality trials on homeopathy are considered for rating, especially for individualized homeopathy, effects on all quality levels according to Cochrane criteria are recognizable, even in the methodologically high-quality studies [4]. A review of 2013 already confirmed that more than 90% of all studies had to be excluded in order to be able to conclude that homeopathy is not effective, a common practice applied in some reviews and meta-analyses on homeopathy with negative outcome [4,26].
By definition, modern evidence-based medicine (EBM) is based on three pillars: the current state of scientific research, the clinical experience of doctors and veterinarians, and the values and wishes of clients and patients [27]. Homeopathy is based on all three pillars of modern evidence-based medicine. There seems to be a confusion in the article ‘A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”’, which describes the different results and outcome variables, that for an intervention to be considered as being effective it needs to be able to be ‘explainable’. In other words, ‘scientific’ can only be associated with explanations of the mode of action of treatments based on the current anatomopathological approach to medicine and that only medical techniques based on these models deserve attention from the research community. However, knowing how a medicine works has never been intended to be a prerequisite for its use according to the founder of modern evidence-based medicine, David Sackett [27]. Aspirin (acetylsalicylic acid) is one of the most widely used drugs in the world, yet it was used for over 70 years before its mechanism of action was discovered in 1971 [28]. Science is a constantly evolving field and what the scientific establishment declares to be ‘impossible’ in one era, is often proved to be ‘fact’ in another [29].
In view of One Health and of the demands of the European Green Deal (Farm2Fork Strategy) and the EU Organic Regulation 2018/848:

(1)
    to reduce the use of antibiotics by 50% throughout the EU by 2030
(2)
    to increase the number of organic farms in the EU from 8% to 25% by 2030
(3)
    to give preference to homeopathy and phytotherapy in organic farms before conventional medicines are used, including antibiotics, the application of these complementary medical disciplines in the sense of integrative veterinary medicine, i.e., to combine best practices of conventional and complementary medical therapy procedures, seems proactive and innovative [30,31]. Hence, the integration of complementary medicine including homeopathy at the universities seems a necessary consequence and requirement in the interests of the patient.

5. Conclusions
Evidence for the effectiveness of human and veterinary homeopathy in general, and in particular in the treatment of infections, has been sufficiently proven to justify further research in homeopathy [32]. Hence, obvious non-scientific interests might consequently have led to misinformation about homeopathy in general and within the article ‘A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”’ [33]. Based on the following three facts, the discussion of the evidence in human and veterinary homeopathy lays the foundations for a comprehensive presentation of the evidence on homeopathy: (a) homeopathic medicinal products without indication are 100% identical with regard to production, quality, safety, and principles of application, regardless of whether they are used in animals or humans; (b) if the simile principle (Similia similibus curentur, or ‘Let like be cured by like’) is adhered to that classical (=individualized) homeopathic therapy is based on the individual and not on the indication; and (c) if the proof of effectiveness of individualized homeopathy in one or more indications is available, the logical consequence seems to be that it can be concluded that it is effective in other indications [34]. Especially for individualized homeopathy, effects on all quality levels according to Cochrane criteria are recognizable, even in the methodologically high-quality studies, when criteria for evidence-based medicine for design, conduction, documentation, and rating of studies in homeopathy are considered, e.g., all high-quality trials on homeopathy are considered for rating [4]. In view of One Health and of the demands of the European Green Deal (Farm2Fork Strategy) and the EU Organic Regulation 2018/848, the application of homeopathy in the sense of integrative veterinary medicine and the integration of complementary medicine including homeopathy at universities seems a necessary consequence and requirement in the interests of the patient, which is already expressed in the American consensus guidelines for an integrative veterinary medicine curriculum and is legally anchored in Switzerland by the Medical Professions Act for university teaching and research [2,3,30,31].
Author Contributions
Conceptualization, P.W.; methodology, P.W.; software, P.W.; validation, M.F., T.P., L.E. and E.D.B.; formal analysis, P.W.; writing—original draft preparation, P.W.; writing—review and editing, M.F., T.P., L.E. and E.D.B.; visualization, M.F.; supervision, M.F.; project administration, P.W. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflict of interest.
References

    Bergh, A.; Lund, I.; Boström, A.; Hyytiäinen, H.; Asplund, K. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356. [Google Scholar] [CrossRef]
    Memon, M.A.; Shmalberg, J.; Adair, H.S., 3rd; Allweiler, S.; Bryan, J.N.; Cantwell, S.; Carr, E.; Chrisman, C.; Egger, C.M.; Greene, S.; et al. Integrative veterinary medical education and consensus guidelines for an integrative veterinary medicine curriculum within veterinary colleges. Open Vet. J. 2016, 6, 44–56. [Google Scholar] [CrossRef] [PubMed]
    Bundesgesetz Über die Universitären Medizinalberufe (Medizinalberufegesetz, MedBG). Available online: https://www.admin.ch/opc/de/classified-compilation/20040265/index.html (accessed on 28 December 2021).
    Weiermayer, P.; Frass, M.; Peinbauer, T.; Ellinger, L. Evidenzbasierte Veterinär-/Homöopathie und ihre mögliche Bedeutung für die Bekämpfung der Antibiotikaresistenzproblematik—Ein Überblick. Schweiz. Arch. Tierheilkd. 2020, 162, 597–615. [Google Scholar] [CrossRef] [PubMed]
    Schmidt, J.M. Organon der Heilkunst, 6th ed.; Elsevier: Munich, Germany, 2003; pp. 4, 38, 43, 45, 119–134, 228–229, 248–251, 274–275. [Google Scholar]
    The European Pharmacopoeia (Ph. Eur.) 10th ed. Available online: https://www.edqm.eu/en/european_pharmacopoeia_10th_edition (accessed on 28 December 2021).
    Homöopathisches Arzneibuch 2021 (HAB 2021); Deutscher Apotheker Verlag: Stuttgart, Germany, 2021; ISBN 978-3-7692-7807-1.
    Relton, C.; O’Cathain, A.; Thomas, K.J. ‘Homeopathy’: Untangling the debate. Homeopathy 2008, 97, 152–155. [Google Scholar] [CrossRef] [PubMed]
    Keller, D.; Sundrum, A. Comparative effectiveness of individualized homeopathy and antibiotics in the treatment of bovine clinical mastitis: Randomized controlled trial. Vet. Rec. 2018, 182, 407. [Google Scholar] [CrossRef] [PubMed]
    Kleijnen, J.; Knipschild, P.; Ter Riet, G. Clinical trials of homeopathy. BMJ 1991, 302, 316–323. [Google Scholar] [CrossRef] [PubMed]
    Linde, K.; Clausius, N.; Ramirez, G.; Melchart, D.; Eitel, F.; Hedges, L.V.; Jonas, W.B. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997, 350, 834–843. [Google Scholar] [CrossRef]
    Linde, K.; Scholz, M.; Ramirez, G.; Clausius, N.; Melchart, D.; Jonas, W.B. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J. Clin. Epidemiol. 1999, 52, 631–636. [Google Scholar] [CrossRef]
    Cucherat, M.; Haugh, M.C.; Gooch, M.; Boissel, J.P. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur. J. Clin. Pharmacol. 2000, 56, 27–33. [Google Scholar] [CrossRef]
    Mathie, R.T.; Lloyd, S.M.; Legg, L.A.; Clausen, J.; Moss, S.; Davidson, J.R.T.; Ford, I. Randomised placebo-controlled trials of individualised homeopathic treatment: Systematic review and meta-analysis. Syst. Rev. 2014, 3, 142. [Google Scholar] [CrossRef]
    Mathie, R.T.; Fok, Y.Y.Y.; Viksveen, P.; To, A.K.L.; Davidson, J.R.T. Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Non-Individualised Homeopathic Treatment. Homeopathy 2019, 108, 88–101. [Google Scholar] [CrossRef]
    Mathie, R.T.; Ramparsad, N.; Legg, L.A.; Clausen, J.; Moss, S.; Davidson, J.R.T.; Messow, C.-M.; McConnachie, A. Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: Systematic review and meta-analysis. Syst. Rev. 2017, 6, 63. [Google Scholar] [CrossRef]
    Mathie, R.T.; Ulbrich-Zürni, S.; Viksveen, P.; Roberts, E.R.; Baitson, E.S.; Legg, L.A.; Davidson, J.R.T. Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Individualised Homeopathic Treatment. Homeopathy 2018, 107, 229–243. [Google Scholar] [CrossRef]
    Bell, I.R.; Lewis, D.A., 2nd; Brooks, A.J.; Schwartz, G.E.; Lewis, S.E.; Walsh, B.T.; Baldwin, C.M. Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology 2004, 43, 577–582. [Google Scholar] [CrossRef]
    Jacobs, J.; Jiménez, L.M.; Gloyd, S.S.; Gale, J.L.; Crothers, D. Treatment of acute childhood diarrhea with homeopathic medicine: A randomized clinical trial in Nicaragua. Pediatrics 1994, 93, 719–725. [Google Scholar] [CrossRef]
    Jacobs, J.; Springer, D.A.; Crothers, D. Homeopathic treatment of acute otitis media in children: A preliminary randomized placebo-controlled trial. Pediatr. Infect. Dis. J. 2001, 20, 177–183. [Google Scholar] [CrossRef]
    Colau, J.-C.; Vincent, S.; Marijnen, P.; Allaert, F.-A. Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: A multicenter, randomized, double-blind, placebo-controlled trial. Drugs R D 2012, 12, 107–119. [Google Scholar] [CrossRef]
    Peckham, E.J.; Relton, C.; Raw, J.; Walters, C.; Thomas, K.; Smith, C.; Kapur, K.; Said, E. Interim results of a randomised controlled trial of homeopathic treatment for irritable bowel syndrome. Homeopathy 2014, 103, 172–177. [Google Scholar] [CrossRef]
    Mathie, R.T.; Clausen, J. Veterinary homeopathy: Meta-analysis of randomised placebo-controlled trials. Homeopathy 2015, 104, 3–8. [Google Scholar] [CrossRef]
    Mathie, R.T.; Clausen, J. Veterinary homeopathy: Systematic review of medical conditions studied by randomised placebo-controlled trials. Vet. Rec. 2014, 175, 373–381. [Google Scholar] [CrossRef]
    El Dib, R.P.; Atallah, A.N.; Anriolo, R.B. Mapping the Cochrane evidence for decision making in health care. J. Eval. Clin. Pract. 2007, 13, 689–692. [Google Scholar] [CrossRef]
    Hahn, R.G. Homeopathy: Meta-Analysis of pooled clinical data. Forsch. Komplement. 2013, 20, 376–381. [Google Scholar] [CrossRef]
    Sackett, D.L.; Rosenberg, W.M.; Gray, J.A.; Haynes, R.B.; Richardson, W.S. Evidence based medicine: What it is and what it isn’t. BMJ 1996, 312, 71–72. [Google Scholar] [CrossRef]
    Vane, J.R.; Botting, R.M. The mechanism of action of aspirin. Thromb. Res. 2003, 110, 255–258. [Google Scholar] [CrossRef]
    Vinci, G.; Rapa, M. Noble Metal Nanoparticles Applications: Recent Trends in Food Control. Bioengineering 2019, 6, 10. [Google Scholar] [CrossRef] [PubMed]
    European Green Deal. Organic Farming—Action Plan for the Development of EU Organic Production. EU Commission. Available online: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12555-Action-plan-for-the-development-of-EU-organic-production (accessed on 28 December 2021).
    Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on Organic Production and Labelling of Organic Products and Repealing Council Regulation (EC) No 834/2007. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32018R0848 (accessed on 28 December 2021).
    Beer, A.-M.; Borchard, U.; Frass, M.; Gerhard, I.; Huber, R.; Keusgen, M.; Martin, D.; Matthes, H.; Pannek, J.; Rychlik, R.P.T. Homöopathie in der medizinischen Versorgung. Gesundh. Ökon. Qual. Manag. 2021, 26, 245–247. [Google Scholar]
    Matthiessen, P. Homöopathie und intellektuelle Redlichkeit—Eine Stellungnahme. Dtsch. Z. Onkol. 2018, 50, 172–177. [Google Scholar] [CrossRef]
    Heads of Medicines Agencies. Homeopathic Medicinal Products Working Group. Available online: https://www.hma.eu/about-hma/working-groups/homeopathic-medicinal-products-working-group.html (accessed on 13 March 2022).

   
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style

Weiermayer, P.; Frass, M.; Peinbauer, T.; Ellinger, L.; De Beukelaer, E. Evidence-Based Human Homeopathy and Veterinary Homeopathy. Comment on Bergh et al. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356. Animals 2022, 12, 2097. https://doi.org/10.3390/ani12162097
AMA Style

Weiermayer P, Frass M, Peinbauer T, Ellinger L, De Beukelaer E. Evidence-Based Human Homeopathy and Veterinary Homeopathy. Comment on Bergh et al. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356. Animals. 2022; 12(16):2097. https://doi.org/10.3390/ani12162097
Chicago/Turabian Style

Weiermayer, Petra, Michael Frass, Thomas Peinbauer, Liesbeth Ellinger, and Edward De Beukelaer. 2022. "Evidence-Based Human Homeopathy and Veterinary Homeopathy. Comment on Bergh et al. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356" Animals 12, no. 16: 2097. https://doi.org/10.3390/ani12162097
[*/quote*]
Logged
Stoppt die deutschen Massenmörder!
Stoppt die österreichischen Massenmörder!
Stoppt die schweizer Massenmörder!

Revolution jetzt. Sonst ist es zu spät.

Pangwall

  • Jr. Member
  • *
  • Posts: 1100
Re: OH SHIT! 'Evidence-Based Human Homeopathy and Veterinary Homeopathy'
« Reply #1 on: February 11, 2023, 05:45:50 PM »

Der Artikel, zu dem die hellsterleuchteten Homöophantasten ihren "Kommentar" geschrieben haben:


https://www.mdpi.com/2076-2615/11/12/3356

[*quote*]
[MDPI Open Access Journals]
Journals Animals Volume 11 Issue 12
10.3390/ani11123356

Comment published on 17 August 2022, see Animals 2022, 12(16), 2097.

A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”
by Anna Bergh
1,* [ORCID] , Iréne Lund
2, Anna Boström
3 [ORCID] , Heli Hyytiäinen
3 [ORCID] and Kjell Asplund
4 [ORCID]
1
Department of Clinical Sciences, Swedish University of Agricultural Sciences, SE 750 07 Uppsala, Sweden
2
Department of Physiology and Pharmacolgy, Karolinska Institutet, SE 171 77 Stockholm, Sweden
3
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 57, 00014 Helsinki, Finland
4
Department of Public Health and Clinical Medicine, Umeå University, SE 901 87 Umeå, Sweden
*
Author to whom correspondence should be addressed.
Animals 2021, 11(12), 3356; https://doi.org/10.3390/ani11123356
Received: 10 October 2021 / Revised: 7 November 2021 / Accepted: 17 November 2021 / Published: 24 November 2021
(This article belongs to the Collection Veterinary Rehabilitation and Sports Medicine)
Download Browse Figure
Review Reports Versions Notes

Simple Summary
Complementary and alternative veterinary medicine (CAVM) is commonly used in animals. However, there is limited knowledge of how the methods affect the animal. Therefore, this study reviews the scientific literature of 24 different CAVM therapies used in cats, dogs, and horses. Three core bibliographic sources were used. Relevant articles were assessed for scientific quality, and information was extracted on study characteristics, species, type of treatment, indication, and treatment effects. Of 982 unique publications screened, 42 were eligible for inclusion, representing nine different CAVM therapies, which were aromatherapy, gold therapy, homeopathy, leeches (hirudotherapy), mesotherapy, mud, neural therapy, sound (music) therapy, and vibration therapy. For the other 15 predefined therapies, no study was identified. The risk of bias was assessed as high in 17 studies, moderate to high in 10, moderate in 10, low to moderate in four, and low in one study. In those studies where the risk of bias was low to moderate, there was considerable heterogeneity in reported treatment effects. Therefore, the 24 CAVM therapies do not have scientific documentation of sufficient quality to draw clear conclusions regarding their clinical effect.
Abstract
There is an increasing interest in complementary and alternative veterinary medicine (CAVM). There is, however, an uncertainty of the efficacy of these methods. Therefore, the aim of this systematic literature review is to assess the evidence for clinical efficacy of 24 CAVM therapies used in cats, dogs, and horses. A bibliographic search, restricted to studies in cats, dogs, and horses, was performed on Web of Science Core Collection, CABI, and PubMed. Relevant articles were assessed for scientific quality, and information was extracted on study characteristics, species, type of treatment, indication, and treatment effects. Of 982 unique publications screened, 42 were eligible for inclusion, representing nine different CAVM therapies, which were aromatherapy, gold therapy, homeopathy, leeches (hirudotherapy), mesotherapy, mud, neural therapy, sound (music) therapy, and vibration therapy. For 15 predefined therapies, no study was identified. The risk of bias was assessed as high in 17 studies, moderate to high in 10, moderate in 10, low to moderate in four, and low in one study. In those studies where the risk of bias was low to moderate, there was considerable heterogeneity in reported treatment effects. Therefore, the scientific evidence is not strong enough to define the clinical efficacy of the 24 CAVM therapies.
Keywords:
aromatherapy; gold therapy; homeopathy; leeches; mesotherapy; mud; neural therapy; music therapy; vibration therapy

1. Introduction
Complementary and alternative veterinary medicine (CAVM) is a term describing a range of therapies that vary in theory and practice. It comprises therapies that are mainly delivered by therapists without a veterinary medical background, and to a minor degree or not at all by animal health personnel. In human medicine, the term CAM is used in contrast to “conventional medicine”, defined as scientifically evidence-based medicine or “well-documented experience”. A key difference compared to conventional medicine is that CAVM methods use explanatory models for their mechanisms of action and clinical effect that either differ from those of conventional medicine or are disputed. An example can be the explanation model with the balancing of energies used in traditional Chinese medicine compared with the activation of endogenous systems with the release of e.g., different neuropeptides used in western medical acupuncture. Based on human literature, there are certain therapies that do not have enough scientific support to determine clinical efficacy but whose mechanisms of action can be explained by natural sciences. These therapies might be more relevant to explore scientifically than those that rest solely upon an explanatory model that is not compatible with existing scientific models. Further, there are also certain therapies for which there is some evidence regarding clinical efficacy in humans, but there is a lack of evidence when it comes to the treatment of animals.
The documentation is also limited regarding how commonly CAVM therapies are used. Some studies report that interest in CAVM has increased in recent years [1,2,3,4]. A study conducted in New Zealand investigated the use of and attitudes towards allied health therapy via interviews with 110 horseback riders and trainers. It showed that 62% used physiotherapy, chiropractic, or massage on their horses. The most commonly used treatment was chiropractic, and the most common indication was equine back pain. Only 7% of respondents chose the relevant method on the recommendation of their veterinarian, and as many as 72% stated that the veterinarian and the therapist did not cooperate during the treatment [2]. In addition, Bergenstrahle and Nielsen (2016) report that a minority of equine veterinarians, answering a survey, had taken CAVM classes during college [5]. Further, the supply of services offered at veterinary clinics has historically been driven by demand from animal owners [6]. Due to the demand from animal owners, veterinarians and other animal health personnel should be well prepared for questions regarding CAVM. There is therefore a need for unbiased information about the possible effects and consequences of the use of CAVM. The aim of the present article is to make a systematic literature review of CAVM therapies that are either rare or do not belong to a specific group of therapies (such as electrotherapies) and are therefore called “miscellaneous therapies”. To the best of the authors’ knowledge, only a limited number of previous systematic reviews match the scope of this article. The exceptions are one meta-analysis, one systematic veterinary medicine literature review of RCTs of homeopathy trials, and a systematic literature review of RCTs in gold therapy [7,8,9].
The present article is one of a future series of systematic review articles in a special issue of Animals on CAVM therapies used in companion animals (cats, dogs, and horses). The other articles will focus on manipulation/mobilization therapies, electrotherapies, soft tissue mobilization, and acupuncture. In the present article, we have collected scientific literature for a number of CAVM interventions, including anthroposophic medicine, aromatherapy, bioresonance, body work, colloidal silver, crystal therapy, healing, gold therapy, healing touch, homeopathy, infrasound, ion therapy, iridology, kinesiology, leeches, mesotherapy, mud therapy, naprapathy, neural therapy, sound therapy, therapeutic touch (a non-contact healing method), vacuum therapy, vibration therapy, reflexology, and zone therapy.
2. Materials and Methods
The overall outline of our systematic review adhered to the Cochrane guidelines on how to perform a systematic review [10], as adapted by the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) in its methodological handbook [11].
2.1. Review Topic/Research Question
To assess the evidence for clinical efficacy of complementary and alternative veterinary medicine (CAVM) therapies used in companion animals, the article covers a range of therapies not included in other reviews in this special issue.
2.2. Search Strategy
Professional librarians performed searches of Web of Science Core Collection, CABI, and PubMed (1980–2020) in August 2020. The keywords were terms relevant to dog OR cat OR horse, AND veterinary medicine OR veterinary, AND therapy* OR treatment*, AND anthroposophic medicine OR aromatherapy* OR bioresonance therapy* OR body work OR colloidal silver OR crystal therapy* OR distance healing OR gold therapy* OR healing touch OR homeopathy OR infrasound therapy* OR iridology OR ion therapy* OR ion therapy* OR kinesiology OR leaches OR leeches OR mesotherapy* OR mud OR naprapathy* OR neural therapy* OR sound/therapy OR sound therapy* OR sound/therapeutic use OR therapeutic touch OR vibration/therapeutic use OR zone therapy* OR reflexology* (* indicates truncation).
2.3. General Inclusion and Exclusion Criteria
The inclusion criteria were that the study must be published in a peer-reviewed journal, be accessible by the authors through institutional access or internet search, and be an original research publication. There were no restrictions with regard to either country or language of publication at the initial search stage. The study should describe the efficacy of one of the above-mentioned therapies in the treatment of a single indication in cats, dogs, or horses. The study design could be randomized controlled trials (RCTs), other interventional studies, or observational studies. Laboratory experimental studies were included only if the study mimicked a clinical situation and/or a mechanism of action was studied. Abstracts were included if no full-length article was available. Case studies were included only if five or more subjects were reported.
The exclusion criterion was any publication that involved more than one type of treatment.
2.4. Study Selection and Categorization
All screening was performed based on journal title, publication title, or abstract. Citations identified were imported into Endnote (X9.3.3, 2018), and duplicates were removed. A single author (AB) applied inclusion and exclusion criteria to all publications.
In the screening phase, we identified articles of possible relevance for the review; articles describing one type of CAVM intervention in cats, dogs, or horses were selected for full text reading. A therapeutic intervention was defined as an intervention intended to reduce the signs, severity, or duration of a clinical condition. After the first stage of screening, articles deemed potentially relevant were accessed from open-access sources. Articles that could not be accessed from digital library resources were requested via the Swedish University of Agricultural Sciences library. If the full manuscript was not found following these steps, but an abstract was available, then categorization was undertaken based on the abstract. For each study, the following key descriptive items were tabulated using templates modified after SBU [11]: first author, year of publication, study design, study population, intervention, type of control, outcome, and relevance (external validity).
Assessment of the risk of bias (scientific quality) of each article was performed in accordance with the Cochrane [10] and SBU [11] guidelines. The assessment was based on the following items: study design, statistical power, deviation from planned therapy, lost to follow-up, type of outcome assessment, and relevance. In the assessment of observational studies, risk of confounding was also included. The manual used for assessment of risk of bias and relevance is available as a Supplementary File. For consistency, before starting the literature review, three of the authors (KA, HH, AB) independently screened a random sample of articles, and differences were discussed and resolved before reviewing all articles.
3. Results
A total of 1222 articles were identified via the three combined electronic database e-searches (see Figure 1).
Animals 11 03356 g001 550
Figure 1. Flow diagram of the stages of the selection process used for identification of studies eligible for final analysis.
The search results were as follows: anthroposophic medicine (1 article), aromatherapy (5), bioresonance (1), body work (6), colloidal silver (7), crystal therapy (22), distance healing (4), gold therapy (145), healing touch (3), homeopathy (644), infrasound (10), ion therapy (5), iridology (0), kinesiology (98), leeches (54), mesotherapy (33), mud therapy (10), naprapathy (0), neural therapy (23), sound therapy (69), therapeutic touch (28), vacuum therapy (32), vibration therapy (16), reflexology (0), and zone therapy (6). Following the removal of duplicate articles, 982 articles were screened for relevance to the review. A large proportion of studies were excluded since they were either published in proceedings or textbook chapters, were experimental studies not mimicking a clinical indication, or were case studies with less than five animals. Following the title and abstract screening, 114 publications investigating treatment of a single indication with any of the listed miscellaneous therapies were evaluated in full. After completion of the selection process, 42 articles concerning nine therapies were retained. The data on the included articles is presented in Table 1, Table 2, Table 3, Table 4 and Table 5, with a description of the article´s content and the level of risk of bias. For the following 15 therapies, no articles were found to fulfil the inclusion criteria: anthroposophic medicine, bioresonance, body work, colloidal silver, crystal therapy, distance healing, healing, infrasound, ion therapy, iridology, kinesiology, naprapathy, therapeutic touch, vacuum therapy, and zone therapy.
Table 1. Aromatherapy.
Table
Table 2. Gold therapy.
Table
Table 3. Homeopathy.
Table
Table 4. Leeches, Mesotherapy, Mud therapy, Neural therapy, and Music/Sound therapy.
Table
Table 5. Vibration therapy.
Table
A total of 42 publications described treatment for 23 different indications, with the largest number of studies regarding treatment of osteoarthritis (6), followed by stress (5), dermatitis (3), and back pain (3). There were 19 publications on horses, 22 on dogs, and four on cats (some including both cats and dogs). In total, the number of animals investigated was 334 horses, 650 dogs, and 63 cats. For horses, the most commonly studied treatment was stress reduction with aromatherapy (3), followed by music therapy (1), different types of lameness treated with vibration therapy (1), and leeches (1). Finally, studies on sound horses investigating treatment effects on different physiological variables such as bone density, movement, and on blood variables were included in the systematic review when other articles were lacking. For dogs, it was treatment of osteoarthritis with gold therapy (4) and homeopathy (2), followed by atopic dermatitis with homeopathy (2) and neural therapy (1), and back pain with mesotherapy (2). For cats, the treatment of malignancy with gold nano-rods illuminated with light was the most commonly studied therapy.
3.1. Aromatherapy
Aromatherapy is a treatment that uses natural plant extracts to promote health and well-being.
Four RCTs, involving a total of 24 horses and five dogs (but none on cats), were identified (see Table 1).
3.1.1. Study Quality
In three studies, the risk of bias was assessed as moderate to high, and in one study, it was assessed as high. The high risk of bias was mainly attributed to low numbers of participants, resulting in insufficient statistical power and suboptimal outcome measures.
3.1.2. Clinical Indications
In all four studies, the method was used for stress reduction in otherwise sound horses and dogs.
3.1.3. Interventions and Controls
The three equine studies involved either aromatherapy with humidified lavender oil or chamomile oil, or just humidified lavender oil, with humidified air as the control. The dosages varied between studies: (1) 100% lavender and chamomile oil, respectively, in a diffuser held under the horse’s nose over two hours; (2) 20% lavender oil, administered by a humidifier for 15 min under the horse’s nose. During this period, an air horn was blown twice, 15 s each time; (3) the same type of lavender dosage (20%), but administered during a 15-min trailer ride. The study on dogs administered lavender oil (0.18 mL) or saline (0.9% NaCl) solution (0.18 mL) topically to the inner pinna of both ears, four times for one day, with no control group.
3.1.4. Outcome Variables
The efficacy of aromatherapy was assessed by monitoring either heart and/or respiratory rate, or heart rate variability. In one study, cortisol and norepinephrine concentration was added to the heart rate registrations. The canine study used an ambulatory ECG monitor to register heart rate and analyzed spectral indices of heart rate variability, power in the high-frequency range, and the ratio of low-frequency to high-frequency power.
3.1.5. Clinical Effects
In the first equine study (high risk of bias), aromatherapy with humidified lavender oil showed a statistically significant difference in heart rate variability compared to the chamomile oil and control. The second equine study (moderate to high risk of bias) showed a significantly lower heart rate after lavender oil than control. The third (moderate risk of bias) showed no difference in heart rate, but a significantly lower concentration of cortisol compared to the control. The canine study reported inconclusive results (see Table 1).
3.2. Gold Therapy
Injectable gold, most commonly used to treat osteoarthritis.
Seven publications were retrieved, of which four reported on RCTs in a total of 218 dogs. Three case series involved a total of 30 dogs and eight cats. No study on horses was identified (see Table 2).
3.2.1. Study Quality
Of the four RCTs, two were graded as having low to moderate risk of bias, one moderate and one high. The case series reports were assessed as having high (one study) or moderate to high risk of bias (two studies). The main reason for high risk was low numbers of participants, resulting in insufficient statistical power, as well as lack of control groups.
3.2.2. Clinical Indications
In two case series, dogs and cats with natural mammary gland tumors were treated with gold nanorod-assisted plasmonic photothermal therapy (PPTT), with no control group. In one case series on dogs, gold wires were used to treat epileptic seizures. The remaining four studies, all RCTs, investigated the effect of gold bead or wire implantation for dogs with osteoarthritis (OA).
3.2.3. Interventions and Controls
In the two case series studies evaluating PPTT, the treatment was (1) one intratumoral injection of 75 μg gold nanorods/kg of body weight followed by direct exposure to 2 W/cm2 near infra-red laser light for 10 min on ablation of mammary tumor; or (2) three sessions of PPTT treatment at two-week intervals with a gold concentration of 7.5 nM. Both studies used an 808 nm diode laser. In the case series study on epileptic seizures, gold wire implants at acupuncture points were used, with no control group. The four RCTs used gold bead or wire implantation around the hip joint, with needle “holes” as control.
3.2.4. Outcome Variables
In the PPTT studies, outcome was assessed via histopathology, diagnostic imaging, laboratory blood analysis, and comprehensive clinical examinations. In the seizure study, outcome was assessed by EEG and a protocol registering the number and intensity of seizures before and after treatment. In the OA studies, clinical examination, owner questionnaires, and kinetic and kinematic analysis were conducted.
3.2.5. Clinical Effects
In the PPTT studies (with moderate-to-high risk of bias), the histopathological results showed a reduction in cancer grade and remission of the tumors. The seizure study (with high risk of bias) showed no changes in EEG recordings but a significant change in owner-reported number of seizures between treatment and control periods. Two of the OA RCTs, graded as being of high and moderate risk of bias, respectively, showed improvements in mobility and reduction of pain for the treated dogs compared to the placebo group. In contrast, the two other RCTs, both with low to moderate risk of bias, showed no differences between the intervention and control groups (see Table 2).
3.3. Homeopathy
Two of the core suppositions of homeopathy are “Like cures like”—the notion that a disease can be cured by a substance that produces similar symptoms in healthy animals and people, as well as “Law of minimum dose”—the notion that the lower the dose of the medication, the greater its effectiveness.
Fifteen publications were retrieved, of which seven reported on RCTs in a total of 213 dogs and 40 cats. Five case series and one case-control study involved a total of 67 horses, 15 cats, and 63 dogs. A prospective observational cohort study involved 68 dogs (see Table 3).
3.3.1. Study Quality
Of the seven RTCs, one was graded as having low risk of bias, three low to moderate, two moderate to high, and one as having high risk of bias. The case series reports, case-control study, prospective observational cohort study, and retrospective study were assessed as having high risk of bias, except for two studies that were graded as having moderate to high risk of bias. The main reason for the assessment “high risk of bias” was low numbers of participants, resulting in insufficient statistical power. Other factors were lack of controls and a high risk of confounding factors affecting the results.
3.3.2. Clinical Indications
Fifteen publications described use of homeopathy for 13 types of indications. One canine study each investigated the effects on asymptomatic heart failure, pseudopregnancy, fear of fireworks, babesiosis, oral papillomatosis, and problems in the immune system. Two studies evaluated effects on OA and atopic dermatitis, respectively. One feline study each investigated eosinophilic granuloma complex and hyperthyroidism. One equine study each looked at stereotypic behaviour, lameness, and laminitis.
3.3.3. Intervention and Controls
The canine study that investigated the hypotensive effect of homeopathy on early (stage B 2) heart failure treated the dogs with Crataegus oxyacantha at a potency of (1) 6cH and (2) Crataegus MT or (3) hydroalcoholic solution (placebo). The canine study on pseudopregnancy treated Group I with: Thuja occidentalis D30 (eight globules, three times a day, per os); Group II: Urtica urens D6 (eight globules, three times a day, per os); Group III: naloxone (control group, 0.01 mg/kg, twice daily, s.c.). The one on fear of fireworks treated subjects with a potentised homeopathic remedy based on phosphorus, rhododendron, borax, theridion, and chamomilla (6C and 30C in 20% alcohol), and a control (placebo) preparation of water and 20% alcohol in an identical bottle with integrated dropper. The one on babesiosis treated Group A with C. horridus 200C, four pills four times a day orally for 14 days, and Group B with diminazene aceturate at 5 mg/kg intramuscularly single dose. All the dogs were administered 5% dextrose normal saline at 60 mL/kg intravenously for four days. The study on oral papillomatosis used homeopathic remedies in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) and placebo (distilled water), administered orally twice daily for 15 days. The study on problems in the immune system treated subjects with a basal diet with an additional dose of 0.5 mL/animal/day homeopathic solution (Echinacea angustifolia 6 CH, Aconitum napellus 30 CH, Veratrum album 30 CH, Pyrogenium 200 CH, Calcarea carbonica 30 CH, and Ignatia amara 30 CH) and controls received only the basal diet (300 g/day).
Two canine studies evaluated the effects on OA and atopic dermatitis, respectively. The dogs with OA were treated with the complex homeopathic preparation Zeel ad us.vet (one to three tablets orally per day depending on body weight) and placebo (lactose capsule) and as active control carprofen (4 mg/kg body weight) over 56 days. The dogs with atopic dermatitis were treated with a combination product Adrisin, three times a day over three weeks, and individualised remedies were prescribed based on the dog’s cutaneous signs and constitutional characteristics.
One feline study investigated the effect on eosinophilic granuloma complex and hyperthyroidism. These included treatment with (1) snake remedies Lachesis (nine cases), Crotalus cascavella (1), Crotalus horridus (1), Cenchris contortrix (1), Elaps corallinus (1), Naja (1) and Vipera (1) for the eosinophilic granuloma complex, and (2) sarcode thyroidinum and an appropriate individualised simillimum using information from a constitutional questionnaire for the hyperthyroidism and a placebo.
One equine study evaluated the effects on stereotypic behaviour, lameness, and laminitis. The treatments were (1) Ignatia and/or Gelsenium, Stramonium, Phosphorus, Nux vomica, Pulsatilla, Hypericum, Lycopodium, Argentum nitricum, Staphysagria, Arsenicum album, Lachesis, and Thuya occidentalis as treatment remedies specific for each horse; (2) hyaluronic acid (control) and complex of 14 homeopathically-prepared ingredients (Zeel, D8); (3) Aconitum 30C, Apis 15C, Arnica 7C, Belladonna 9C, Bryonia 9C and Nux vomica 9C (two granules of each component were administered 10 times per day for 10 days).
3.3.4. Outcome Variables
The outcome variables for the canine studies were clinical examination, blood analysis, ECG, different types of assessment scales, owner questionnaires, and force plate. The outcome variables for the feline studies were clinical examination and T4 values. The outcome measures for the equine studies were clinical examination, owner questionnaires and blood analysis.
3.3.5. Clinical Effects
The canine study, of moderate to high risk of bias, which investigated the hypotensive effect of homeopathy on early-stage (B2) myxomatous mitral valve disease showed no difference between groups. The one on pseudopregnancy, concerning mammary gland scores, yielded significantly higher success rates in treated groups compared to the control group (moderate-to-high risk of bias). The one on fear of fireworks showed no difference between groups, based on owner’s rating (moderate to high risk of bias). The one on babesiosis, with high risk of bias, showed no difference between groups. The study on oral papillomatosis showed early recovery with a significant reduction in oral lesions reflected by clinical score in comparison to the placebo-treated group (moderate-to-high risk of bias). The study on problems in the immune system, with high risk of bias, reported that lymphocyte counts were greater in the treatment group on days 30 and 45 of the experiment. The two studies on atopic dermatitis, as well as one on OA, showed no difference between groups (all three studies with high risk of bias). In the remaining low to moderate risk of bias study on OA, when the outcome was measured by dichotomous responses of ‘improved’ or ‘not improved’, three out of the six variables showed a significant difference in improved dogs per group between the treated group and the placebo group.
One feline study investigated the effect on the eosinophilic granuloma complex (high risk of bias) and hyperthyroidism (low risk of bias), with negative results.
One equine study on stereotypic behavior showed, by owner reports, a decrease in stereotypic behavior (high risk of bias). The one on lameness showed a reduction in lameness based on clinical examination (moderate to high risk of bias). The one on laminitis, with high risk of bias, showed a clinical improvement after one day (see Table 3).
3.4. Leeches (Hirudotherapy)
Hirudotherapy is a treatment using medicinal leeches.
One retrospective cohort study involving 57 horses was identified (see Table 4).
3.4.1. Study Quality
The publication had high risk of bias due to its study design with a lack of control group and a high risk of confounding factors.
3.4.2. Clinical Indication, Intervention and Control, and Outcome Variables
The study described the treatment with 117 leech applications with many different types of treatment protocols, in 57 horses with laminitis. An Obel scale assessed the efficacy of the treatment.
3.4.3. Clinical Effects
A total of 84% of the horses showed clinical improvement after treatment, based on this high risk of bias study.
3.5. Mesotherapy
Mesotherapy is a non-invasive non-surgical technique that uses micro-injections of pharmaceutical and homeopathic preparations, plant extracts, vitamins, and other ingredients into subcutaneous fat.
One RCT involving 15 dogs and one retrospective cohort study involving 20 dogs were identified (see Table 4).
3.5.1. Study Quality
The RCT study was judged as having a moderate risk of bias and the retrospective study as moderate to high risk, due to the study design and low numbers of participants.
Clinical indications.
The method was used in dogs to treat chronic back pain.
3.5.2. Interventions and Controls
The RCT study compared active mesotherapy treatment (n = 10) with control treatment (n = 5). The active treatment group received a combination of 140 mg lidocaine, 15 mg dexamethasone, and 20 mg thiocolchicoside along with a 70-day course of a placebo, administered as if it was carprofen. The control group received carprofen for 70 days, at a dose adjusted to their weight. Further, on day 0, an intradermal injection of Ringer’s lactate was also administered. Animals in both groups rested for three days and resumed normal activity over a five-day period. The retrospective study used (1) a combination of lidocaine, dexamethasone, and thiocolchicoseide, and (2) as previous with an additional traumeel LT.
3.5.3. Outcome Variables
Response to treatment, measured by the Canine Brief Pain Inventory (CBPI) and the Hudson Visual Analogue Scale (HVAS), was evaluated before treatment, after 15 days, and after one, two, three, four, and five months.
3.5.4. Clinical Effects
When comparing CBPI results in the RCT study (with a moderate risk of bias), no differences were found between the treatment group (TG) and control group at baseline through two and five months. Differences were observed in CBPI sections after the discontinuation of carprofen: at three months for Pain Interference Score (PIS) and Pain Severity Score (PSS) and at four months for PIS and for PSS, with group TG having overall better results. No differences were registered with the HVAS. In the retrospective study (with high risk of bias), no differences were observed between groups.
3.6. Mud Therapy
Mud therapy involves treating conditions with mineral-rich water mud.
One case study involving 10 sound horses was identified (see Table 4).
3.6.1. Study Quality
The publication had high risk of bias due to a study design with a lack of control group, limited number of participants and a high risk of confounding factors possibly affecting the result.
3.6.2. Clinical Indication, Intervention and Control, and Outcome Variables
The method was used in horses to enhance joint flexibility and movement. Horses were treated with mud from Lake Hévíz in Hungary 10 times, twice daily in the evenings. Before and after the experiment and eight weeks following it, measurements were taken of the average stride length and the longest distance between the hind and front foot during walking and trotting, and maximal flexibility of knee, hock, and fetlock joints. The maximal flexibility of each joint was measured with a joint protractor. There were no controls included in the study.
3.6.3. Clinical Effects
The authors of this high risk of bias study reported that the mud treatment had a positive and durable effect on the joints and movement.
3.7. Neural Therapy
Neural therapy is a treatment in which local anesthetic is injected into certain locations of the body.
Two case studies involving 18 dogs and 60 horses were identified (see Table 4).
3.7.1. Study Quality
The studies’ risk of bias was judged as high, due to the study design (case studies) and no control groups.
3.7.2. Clinical Indications
Neural therapy (NT) was used for canine atopic dermatitis in 18 dogs and for pain syndrome in the loin and hip region of 60 horses.
3.7.3. Interventions and Controls
The dogs were treated with one set of NT, given by injecting an intravenous dose of 0.1 mg/kg of a 0.7% procaine solution, followed by 10 to 25 intradermal injections of the same solution in a volume of 0.1–0.3 mL per site. Dogs were given between six and 13 sets of injections. There were no controls. The horses were treated with lidocaine, 5 mL of a 1% solution without additives for each point, usually by segmental infiltration of skin, muscles, and spinal nerve roots at eight to 14 segments. This infiltration was repeated each third day, four to five times. There were no controls.
3.7.4. Outcome Variables
In the canine study, the dermatological condition of each patient was evaluated before and after the treatment using two scales: the pruritus visual analogue scale (PVAS) and the canine atopic dermatitis extent and severity index (CADESI). In the equine study, clinical examination was used as an outcome measure, as well as return to racing.
3.7.5. Clinical Effects
In the canine study (high risk of bias), the reduction of pruritus was significant comparing before and after treatment. The equine study (with high risk of bias) reported that of the 60 patients, 51 horses were treated with infiltration, and of those, 45 were assessed after treatment. Seven of them were no longer used for competition, and in four horses, the evaluation time after treatment was too short. Of the remaining 34 horses, 26 could be trained successfully and won several races through the following years, while eight horses did not recover.
3.8. Sound (Music) Therapy
Sound (music) therapy uses sound and music to improve health and wellbeing.
One RCT involving 60 sound horses was identified (see Table 4).
3.8.1. Study Quality
The study´s risk of bias was high due to study design. Further, performance variables such as success coefficient in racing season could have been influenced by factors other than the treatment.
3.8.2. Clinical Indications, Dosage, and Outcome Variables
The method was used in horses to reduce stress. The study described the treatment in five different groups (n = 60; one control and four experimental groups) with music for one hour a day, music for three hours a day, massage on the day preceding a race, and daily massage during the six months of the racing season, plus a control group. The efficacy of the treatment was assessed by registering the horses’ heart rate (HR) and variables of heart rate variability (ratio of low to high frequencies of the power spectrum–LF/HF), and root mean square of successive beat-to-beat difference [RMSSD]), which were measured while preparing horses for training sessions. Salivary cortisol concentrations were measured before and after training sessions. Official general handicap and success coefficient in the racing season were considered as performance variables.
3.8.3. Clinical Effects
The study, with a high risk of bias, reports that playing relaxing music for three hours a day had more positive effects on horses’ emotional state than music for one hour, evaluated by heart rate (see Table 4).
3.9. Vibration Therapy
Vibration therapy is when vibrations are transferred to the body through a contact surface that is in a mechanical vibrating state.
Five RCTs involving 79 sound horses, three case studies involving 25 horses, and one case study involving 10 dogs were identified (see Table 5).
3.9.1. Study Quality
The risk of bias in the RCTs was judged as low to moderate (1) and moderate (4). The case studies were judged as having a moderate to high (2) and high risk of bias (2).
3.9.2. Clinical Indications
One case study concerned the treatment of horses with chronic lameness with whole-body vibration (WBV). One equine study looked at cycloidal vibration therapy on sound horses, while the remaining equine studies investigated the different types of physiological effects of WBV on sound horses. One case study examined physiological changes in sound dogs.
3.9.3. Interventions and Controls
In the case study on horses with chronic lameness, the horses stood on a vibration plate for 30 min a day, five days a week for 60 days, and there was no control group. The seven studies on sound horses described treatments varying from 10 min vibration (15–25 Hz) to 45 min, five days a week (30 Hz). The study on dogs used WBV exercise in daily sessions at 30 Hz for five minutes, followed by 50 Hz for five minutes, and finally 30 Hz in five minutes over five days. Acceleration range was 12–40 m/s2 and amplitude was 1.7–2.5 mm. The five RCT studies had control groups; the other studies reported changes before and after treatment.
3.9.4. Outcome Variables
In the study on horses with chronic lameness, the horses were assessed by clinical examination and inertial measurement unit technique. The seven studies experimenting on sound horses used outcome tools such as radiographs measuring bone mineral content and laboratory blood analysis of different blood variables. The study on dogs used complete blood count and serum chemistry.
3.9.5. Clinical Effect
In the study on horses with chronic lameness, there was no difference in lameness seen after 30 or 60 days of WBV (moderate-to-high risk of bias). The seven studies on sound horses (moderate to high risk of bias), which used radiographs measuring bone mineral content and laboratory blood analysis of different blood variables as outcome measures, showed a decrease in gamma-glutamyltransferase, serum cortisol, and creatinkinase values, but there were no changes in the other registered variables. The study on dogs, with high risk of bias, reported that the treatment did not cause adverse effects on hematology and serum biochemistry in healthy adult dogs (see Table 5).
4. Discussion
This systematic review demonstrates a large number of publications on a wide variety of CAVM therapies, accessible through database searches. However, the absolute majority of these publications are methodology or overview articles. Thus, for most therapies, there are few or no scientific articles describing the clinical efficacy of a single type of indication in the species cat, dog, or horse. Of the publications that met the inclusion criteria, the majority did not have scientific documentation of sufficient quality to draw conclusions regarding their effect, assessed as the studies’ ”risk of bias”.
It is important that animal health personnel have a general knowledge of CAVM therapies in order to be able to answer questions from the increasing number of animal owners interested in CAVM. The respondents in a US survey of colleges and schools of veterinary medicine [54] stated that the level of public interest makes it necessary for veterinary students to be prepared for questions about CAVM, but that the inclusion of CAVM courses in veterinary medicine must be based on evidence. Regardless of the veterinarian´s private opinion on CAVM, knowledge about the scientific basis for information on the advantages and disadvantages of using CAVM is essential in situations where the animal owner addresses the matter. Otherwise, owners may choose to use CAVM without telling their veterinarian, as human patients tend to do with regards to their doctor [55]. Thus, there is a need for unbiased information regarding the scientific evidence for CAVM therapies.
In the present systematic literature review, 15 therapies out of 24 had no scientific documentation that matched the inclusion criteria, despite the criteria being broad. The reasons for the lack of scientific documentation can be speculated. For instance, there could be a lack of funding within the CAVM community, and limited experience of conducting research and the willingness to deposit means for research and development may be limited. Another explanation may be low demand for scientific evidence of efficacy, as few CAVM customers ask for scientific documentation. Further, there might be skepticism among CAVM therapists towards conventional medicine and the design of scientific studies. Further, an explanation for the lack of research may be that it is not possible due to the characteristics of a particular CAVM method. This applies especially for those therapies that have an explanatory model that is different from those used in conventional medicine; for example, the use of RCTs when studying individualized homeopathic treatment [7,31].
The results of the present review indicate that the included therapies are used in a variety of indications. Some therapies treat animals with a specific pathology, mainly skin disease, malignancies, or lameness. Others aim at affecting behavior or have defined physiological effects, such as enhancing bone mineral content. It is possible that indications for which conventional veterinary medicine offers an extensive program of treatment or recommends changes in training are more frequently treated with CAVM. As an example, back pain in horses is often regarded as difficult to treat [56], which may make veterinarians more likely to try CAVM as a complement to conventional medicine [5]. Thus, therapies such as acupuncture and chiropractic can be offered for back pain and if horse owners have an interest in CAVM [57]. Further, the range of services offered at veterinary clinics has historically been driven by demand from pet owners [6,57].
Despite the limited number of scientific publications, four studies were identified with a lower risk of bias, which indicates that the study result can be considered more reliable over time. Of these, no significant difference between treated and control group was reported in two studies each, on homeopathy and on gold implants, respectively. The two RCTs on gold implants into acupuncture points around hip joints in dogs with osteoarthritis showed no difference in the dogs’ movement. These negative findings are consistent with the results of a previous literature review including three RCTs, three retrospective, and five case studies [9], concluding that the case and retrospective studies, with a higher risk of bias, showed therapeutic success. However, the studies with a lower risk of bias showed no differences, and the single included RCT study with objective evaluation of the treatment effect showed no differences between treatment and placebo groups.
A similar pattern emerges from the studies on homeopathy The included studies, with moderate risk of bias, such as homeopathic hypotensive treatment in dogs with early, stage two heart failure and the study on cats with hyperthyroidism, showed no differences between treated and non-treated animals. An RCT on treatment of osteoarthritic dogs showed a difference in three of the six variables (veterinary-assessed mobility, two force plate variables, an owner-assessed chronic pain index, and pain and movement visually analogous scales). These results on homeopathy are supported by another systematic literature review of 18 RCTs, representing four species (including two dog studies) and 11 indications [7]. The authors excluded generalized conclusions about the effect of certain homeopathic remedies or the effect of individualized homeopathic intervention on a given medical condition in animals. In addition, the meta-analysis of nine homeopathy trials with a high risk of bias, and two studies with a lower risk of bias, conclude that there is very limited evidence that clinical intervention in animals using homeopathic remedies can be distinguished from similar placebo interventions [8].
Most studies on vibration therapy examined the physiological effect of treatment on sound horses. These studies had a moderate to high risk of bias and showed no effect on bone density, muscle activity or joint mobility, or stride length. The results are partly opposite to those from human medicine, where there are indications that vibration treatment results in increased bone density [58]. The scope and quality of the scientific documentation for other therapies was such that no conclusions can be drawn regarding the methods’ effectiveness in treating current animal species and indications.
As the aim of the literature review was to evaluate the efficacy of the treatments in sport and companion animals, the search was restricted to the species horses, dogs, and cats. It is likely that if more species had been included, additional publications could have been found. It is possible that some additional knowledge could have been extracted from these potential studies. However, extrapolating results between species can be unsafe, as different species have different pathologies and areas of use. Further, in order to ensure the specific efficacy of each method, no combination of therapies was included.
One major problem with drawing clinically applicable conclusions from the included articles is the diversity of study design. Less than half of the studies were RCTs, the minority used similar treatment protocols, and the main outcome variables were either subjective or measures that are easily influenced by other factors than the treatment, such as owner questionnaires, visual lameness examinations, or clinical examinations assessing heart or respiratory rates. Another problem is the small sample sizes with low statistical power and not allowing the detection of small differences between the treatment groups and controls. Therefore, most of the studies were classified as having moderate to high risk of bias based on templates developed by the Cochrane Collaboration [10] and SBU [11]. The grading criteria included study design, study population, type of control, confounding factors, classification/selection, deviation from planned therapy, lost to follow-up, type of outcome assessment, and relevance. It is unlikely that, with another type of grading, a different result would have been reached. Thus, it is most unlikely that the overall conclusion would have been different.
In a few of the CAVM studies, statistically significant results in favor of the active therapy were reported. In the evaluation of these results, it is essential to take not only statistical but also clinical significance (effect size) into account. When statistical differences were reported, either the effect size was of questionable clinical significance, or the results were not replicated in independent studies. Further, the description of the majority of studies did not enable reports of the minimal clinically important difference, defined as the smallest difference in score in any domain or outcome of interest that is perceived as beneficial.
Limitations
The primary limitation for drawing conclusions on treatment efficacy from this systematic review is the lack of publications and high heterogeneity in terms of indications, applied techniques, treatment protocols, and outcome variables across studies.
Professional librarians performed the literature search, and the search words were selected after a pilot literature search. The broad search strategy that was used had low specificity; only 42 of 982 articles (4%) fulfilled the inclusion criteria. It is possible that a few, more marginal, search terms (for instance hirudotherapy added to leeches or clay to mud therapy) would have resulted in a limited number of additional articles to be reviewed in full text. It is, however, unlikely that more than sporadic such articles would have fulfilled the inclusion criteria at a final review.
A systematic literature review attempts to gather available empirical research by clearly defined, systematic methods to obtain answers to specific questions. Since the number of studies was low for each species/indication/therapy combination, a pooled statistical analysis with meta-analysis was not feasible. In addition, when a narrative approach is used, as we have done, it is difficult to obtain an interpretable overview of the scientific documentation due to the high heterogeneity of study designs.
5. Conclusions
The present systematic review has revealed significant gaps in scientific knowledge regarding the effects of a number of “miscellaneous” CAVM methods used in cats, dogs, and horses. For the majority of the therapies, no relevant scientific articles were retrieved. For nine therapies, some research documentation was available. However, due to small sample sizes, a lack of control groups, and other methodological limitations, few articles with a low risk of bias were identified. Where beneficial results were reported, they were not replicated in other independent studies. Many of the articles were in the lower levels of the evidence pyramid, emphasising the need for more high-quality research using precise methodologies to evaluate the potential therapeutic effects of these therapies. Of the publications that met the inclusion criteria, the majority did not have any scientific documentation of sufficient quality to draw any conclusion regarding their effect. Several of our observations may be translated into lessons on how to improve the scientific support for CAVM therapies. Crucial efforts include (a) a focus on the evaluation of therapies with an explanatory model for a mechanism of action accepted by the scientific community at large, (b) the use of appropriate control animals and treatments, preferably in randomized controlled trials, (c) high-quality observational studies with emphasis on control for confounding factors, (d) sufficient statistical power; to achieve this, large-scale multicenter trials may be needed, (e) blinded evaluations, and (f) replication studies of therapies that have shown promising results in single studies.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/ani11123356/s1. Manual for assessment of risk of bias and relevance.
Author Contributions
Conceptualization, all authors; methodology, all authors; formal analysis, A.B. (Anna Bergh); data curation, A.B. (Anna Bergh); writing—original draft preparation, A.B. (Anna Bergh); writing—review and editing, all authors.; funding acquisition, A.B. (Anna Bergh). All authors have read and agreed to the published version of the manuscript.
Funding
This systematic literature review was partly funded by SLU Future One Health, Swedish University of Agricultural Sciences; Grant number: SLU.ua.2020.4.2-3148.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Acknowledgments
The authors thank the most helpful and professional librarians, Åsa Ode, Britt-Marie Bergquist and Jenny Casey Eriksson, responsible for developing the search strategy and creation of the initial reference library to review.
Conflicts of Interest
The authors declare no conflict of interest.
References

    Lana, S.E.; Kogan, L.R.; Crump, K.A.; Graham, J.T.; Robinson, N.G. The use of complementary and alternative therapies in dogs and cats with cancer. J. Am. Anim. Hosp. Assoc. 2006, 42, 361–365. [Google Scholar] [CrossRef]
    Meredith, K.; Bolwell, C.F.; Rogers, C.W.; Gee, E.K. The use of allied health therapies on competition horses in the North Island of New Zealand. N. Z. Vet. J. 2011, 59, 123–127. [Google Scholar] [CrossRef] [PubMed]
    Riccio, B.; Fraschetto, C.; Villanueva, J.; Cantatore, F.; Bertuglia, A. Two multicenter surveys on equine back-pain 10 years apart. Front. Vet. Sci. 2018, 5, 195. [Google Scholar] [CrossRef]
    Wilson, J.M.; McKenzie, E.; Duesterdieck-Zellmer, K. International survey regarding the use of rehabilitation modalities in horses. Front. Vet. Sci. 2018, 5, 120. [Google Scholar] [CrossRef][Green Version]
    Bergenstrahle, A.; Nielsen, B.D. Attitude and behavior of veterinarians surrounding the use of complementary and alternative veterinary medicine in the treatment of equine musculoskeletal pain. J. Equine Vet. Sci. 2016, 45, 87–97. [Google Scholar] [CrossRef]
    Loomans, J.B.A.; Stolk, P.W.T.; Weeren, P.R.; van Vaarkamp, H.; Barneveld, A. A survey of the workload and clinical skills in current equine practices in The Netherlands. Equine Vet. Educ. 2007, 19, 162–168. [Google Scholar] [CrossRef]
    Mathie, R.T.; Clausen, J. Veterinary homeopathy: Meta-analysis of randomised placebo-controlled trials. Homeopathy 2015, 104, 3–8. [Google Scholar] [CrossRef] [PubMed]
    Mathie, R.T.; Clausen, J. Veterinary homeopathy: Systematic review of medical conditions studied by randomised placebo-controlled trials. Vet. Rec. 2014, 175, 373–381. [Google Scholar] [CrossRef] [PubMed][Green Version]
    Deisenroth, A.; Nolte, I.; Wefstaedt, P. Use of gold implants as a treatment of pain related to canine hip dysplasia—A review. Part 2: Clinical trials and case reports. Tierarztl. Prax. 2013, 41, 244–254. [Google Scholar] [CrossRef]
    Higgins, J.; Thomas, J. (Eds.) Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2. 2021. Available online: https://training.cochrane.org/handbook/current (accessed on 19 November 2021).
    Statens Beredning för Medicinsk och Social Utvärdering (SBU). Utvärdering av Metoder i hälso- och Sjukvården och Insatser i Socialtjänsten: En Metodbok [in Swedish]. Stockholm. 2020. Available online: https://www.sbu.se/globalassets/ebm/metodbok/eng_metodboken_no-longer-in-use.pdf (accessed on 19 November 2021).
    Baldwin, A.L.; Chea, I. Effect of aromatherapy on equine heart rate variability. J. Equine Vet. Sci. 2018, 68, 46–50. [Google Scholar] [CrossRef]
    Ferguson, C.R.; Kleinman, H.F.; Browning, J. Effect of lavender aromatherapy on acute-stressed horses. J. Equine Vet. Sci. 2013, 33, 67–69. [Google Scholar] [CrossRef]
    Heitman, K.; Rabquer, B.; Heitman, E.; Streu, C.; Anderson, A. The use of equine lavender aromatherapy to relieve stress in trailered horses. J. Equine Vet. Sci. 2018, 63, 8–12. [Google Scholar] [CrossRef]
    Komiya, M.; Sugiyama, A.; Tanabe, K.; Uchino, T.; Takeuchi, T. Evaluation of the effect of topical application of lavender oil on autonomic nerve activity in dogs. Am. J. Vet. Res. 2009, 70, 764–769. [Google Scholar] [CrossRef] [PubMed]
    Abdoon, A.S.; Al-Ashkar, E.A.; Kandil, O.M.; Shaban, A.M.; Khaled, H.M.; El Sayed, M.A.; El Shaer, M.M.; Shaalan, A.H.; Eisa, W.H.; Gamal, E.A.A.; et al. Efficacy and toxicity of plasmonic photothermal therapy (PPTT) using gold nanorods (GNRs) against mammary tumors in dogs and cats. Nanomed. Nanotechnol. Biol. Med. 2016, 12, 2291–2297. [Google Scholar] [CrossRef]
    Ali, M.; Ibrahim, I.; Ali, H.; Selim, S.; El-Sayed, M.A. Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis. Int. J. Nanomed. 2016, 11, 4849–4863. [Google Scholar]
    Goiz-Marquez, G.; CaballeroS, S.H.; Rodriguez, C.; Sumano, H. Electroencephalographic evaluation of gold wire implants inserted in acupuncture points in dogs with epileptic seizures. Res. Vet. Sci. 2009, 86, 152–161. [Google Scholar] [CrossRef] [PubMed]
    Hielm-Bjorkman, A.; Raekallio, M.; Kuusela, E.; Saarto, E.; Markkola, A.; Tulamo, R.M. Double-blind evaluation of implants of gold wire at acupuncture points in the dog as a treatment for osteoarthritis induced by hip dysplasia. Vet. Rec. 2001, 149, 452–456. [Google Scholar] [CrossRef] [PubMed]
    Jaeger, G.T.; Larsen, S.; Søli, N.; Moe, L. Double-blind, placebo-controlled trial of the pain-relieving effects of the implantation of gold beads into dogs with hip dysplasia. Vet. Rec. 2006, 158, 722–726. [Google Scholar] [CrossRef]
    Bollinger, C.; Decamp, C.E.; Stajich, M.; Flo, G.L.; Martinez, S.A.; Bennett, R.L.; Bebchuk, T. Gait analysis of dogs with hip dysplasia treated with gold bead implantation acupuncture. Vet. Comp. Orthop. Traumatol. 2002, 15, 116–122. [Google Scholar]
    Jaeger, G.T.; Larsen, S.; Søli, N.; Moe, L. Two years follow-up study of the pain-relieving effect of gold bead implantation in dogs with hip-joint arthritis. Acta Vet. Scand. 2007, 49, 9. [Google Scholar] [CrossRef] [PubMed][Green Version]
    Balbueno, M.C.S.; Peixoto, K.C.; Coelho, C.P. Evaluation of the efficacy of Crataegus oxyacantha in dogs with early-stage heart failure. Homeopathy 2020, 109, 224–229. [Google Scholar] [CrossRef]
    Boehm, T.; Klinger, C.J.; Udraite, L.; Muelle, R.S. Effects of a homeopathic medication on clinical signs of canine atopic dermatitis. Tierarztl. Prax. 2020, 48, 245–248. [Google Scholar]
    Neumann, S.; Stolt, P.; Braun, G.; Hellmann, K.; Reinhart, E. Effectiveness of the homeopathic preparation Zeel compared with carprofen in dogs with osteoarthritis. J. Am. Anim. Hosp. Assoc. 2011, 47, 12–20. [Google Scholar] [CrossRef]
    Beceriklisoy, H.B.; Ozyurtlu, N.; Kaya, D.; Handler, J.; Aslan, S. Effectiveness of Thuja occidentalis and Urtica urens in pseudopregnant bitches. Wien. Tierarztl. Mon. 2008, 95, 12–20. [Google Scholar]
    Hielm-Björkman, A.; Tulamo, R.M.; Salonen, H.; Raekallio, M. Evaluating complementary therapies for canine osteoarthritis—Part ii: A homeopathic combination preparation (Zeel). eCAM 2009, 6, 465–471. [Google Scholar] [CrossRef] [PubMed]
    Cracknell, D.; Mills, S. A double-blind placebo-controlled study into the efficacy of a homeopathic remedy for fear of firework noises in the dog (Canis familiaris). Vet. J. 2008, 177, 80–88. [Google Scholar] [CrossRef] [PubMed]
    Aboutboule, R. Snake remedies and eosinophilic granuloma complex in cats. Homeopathy 2006, 95, 15–19. [Google Scholar] [CrossRef] [PubMed]
    Chaudhury, S.; Varshney, J.P. Clinical management of babesiosis in dogs with homeopathic Crotalus horridus 200C. Homeopathy 2007, 96, 90–94. [Google Scholar] [CrossRef]
    Hill, P.B.; Hoare, J.; Lau-Gillard, P.; Rybnicek, J.; Mathie, R.T. Pilot study of the effect of individualised homeopathy on the pruritus associated with atopic dermatitis in dogs. Vet. Rec. 2009, 164, 364–370. [Google Scholar] [CrossRef]
    Yaramiş, C.P.; Issautier, M.N.; Ulgen, S.S.; Demirtaş, B.; Olgun, E.D.; Or, M.E. Homeopathic treatments in 17 horses with stereotypic behaviours. Kafkas Univ. Vet. Fak. Derg. 2016, 22, 793–799. [Google Scholar] [CrossRef]
    Raj, P.A.A.; Pavulraj, S.; Kumar, M.A.; Sangeetha, S.; Shamugapriya, R.; Sabithabanu, S. Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis. Vet. World 2020, 13, 206–213. [Google Scholar] [CrossRef] [PubMed][Green Version]
    Bodey, A.L.; Almond, C.J.; Holmes, M.A. Double-blinded randomised placebo-controlled clinical trial of individualised homeopathic treatment of hyperthyroid cats. Vet. Rec. 2017, 180, 377. [Google Scholar] [CrossRef][Green Version]
    Marchiori, M.S.; Schafer Da, S.A.; Glombowsky, P.; Campigotto, G.; Favaretto, J.A.R.; Jaguezeski, A.M. Homeopathic product in dog diets modulate blood cell responses. Arch. Vet. Sci. 2019, 24, 92–101. [Google Scholar] [CrossRef]
    Faulstich, A.; Lutz, H.; Hellmann, K. Comparison of the effed of Zeel® ad us. vet. in lameness of horses caused by non-infectious arthropathy to the effect of hyaluronic acid. Der Prakt. Tierarzt. 2006, 87, 362–370. [Google Scholar]
    Cayado, P. Effectiveness of homeopathic remedies in severe laminitic horses. Homeopathy 2016, 105, 27. [Google Scholar] [CrossRef]
    Rasch, K. Blutegeltherapie bei Hufrehe der Pferde. Ergebnisse einer bundesweiten Studie. Z. Fur Ganzheitl. Tiermed. 2010, 24, 24–29. [Google Scholar] [CrossRef]
    Alves, J.C.; Santos, A.; Fernandes, A. Evaluation of the effect of mesotherapy in the management of back pain in police working dogs. Vet. Anaesth. Analg. 2018, 45, 123–128. [Google Scholar] [CrossRef] [PubMed]
    Alves, J.; Jorge, P.; Santos, A. Comparison of two mesotherapy protocols in the management of back pain in police working dogs: A retrospective study. Top. Companion Med. 2021, 43, 100519. [Google Scholar] [CrossRef]
    Bartos, A.; Bányai, A.; Koltay, I.; Ujj, Z.; Such, N.; Mándó, Z.; Novinszky, P. Veterinary use of thermal water and mud from Lake Hévíz for equestrian injury prevention and rehabilitation. Ecocycles 2019, 5, 19–23. [Google Scholar] [CrossRef]
    Bravo-Monsalvo, A.; Vázquez-Chagoyán, J.C.; Gutiérrez, L.; Sumano, H. Clinical efficacy of neural therapy for the treatment of atopic dermatitis in dogs. Acta Vet. Hung. 2008, 56, 459–469. [Google Scholar] [CrossRef][Green Version]
    Eisenmenger, E.; Kasper, I.; Eisenmenger, M. Observations of the pain syndrome in theloin and hip region of horses and experimental treatment with neural therapy. Pferdeheilkunde 1989, 5, 193–199. [Google Scholar] [CrossRef]
    Kedzierski, W.; Janczarek, I.; Stachurska, A.; Wilk, I. Comparison of effects of different relaxing massage frequencies and different music hours on reducing stress level in race horses. J. Equine Vet. Sci. 2017, 53, 100–107. [Google Scholar] [CrossRef]
    Buchner, H.H.F.; Zimmer, L.; Haase, L.; Perrier, J.; Peham, C. Effects of whole body vibration on the horse: Actual vibration, muscle activity, and warm-up effect. J. Equine Vet. Sci. 2017, 51, 54–60. [Google Scholar] [CrossRef]
    Halsberghe, B.T. Long-term and immediate effects of whole body vibration on chronic lameness in the horse: A pilot study. J. Equine Vet. Sci. 2017, 48, 121–128. [Google Scholar] [CrossRef]
    Mackechnie-Guire, R.; Mackechnie-Guire, E.; Bush, R.; Wyatt, R.D.; Fisher, M.; Cameron, L. A controlled, blinded study investigating the effect that a 20-minute cycloidal vibration has on whole horse locomotion and thoracolumbar profiles. J. Equine Vet. Sci. 2018, 71, 84–89. [Google Scholar] [CrossRef]
    Carstanjen, B.; Balai, M.; Gajewski, Z.; Furmanczyk, K.; Bondzio, A.; Remy, B.; Hartmann, H. Short-term whole body vibration exercise in adult healthy horses. Pol. J. Vet. Sci. 2013, 16, 403–405. [Google Scholar] [CrossRef][Green Version]
    Santos, I.F.C.; Rahal, S.C.; Shimono, J.; Rahal, S.C.; Tsunemi, M.; Takahira, R.; Teixeira, R.C. Whole-body vibration exercise on hematology and serum biochemistry in healthy dogs. Top. Companion Anim. Med. 2017, 32, 86–90. [Google Scholar] [CrossRef][Green Version]
    Nowlin, C.; Nielsen, B.; Mills, J.; Robison, C.; Schott, H.; Peters, D. Acute and prolonged effects of vibrating platform treatment on horses: A pilot study. J. Equine Vet. Sci. 2018, 62, 116–122. [Google Scholar] [CrossRef]
    Hyatt, C.S.; Sigler, D.; Vogelsang, M. Muscle metabolic effects of whole-body vibration in yearling horses. J. Equine Vet. Sci. 2017, 52, 64–72. [Google Scholar] [CrossRef]
    Maher, K.; Spooner, H.; Hoffman, R.; Haffner, J. The effect of whole body vibration on bone density and other parameters in the exercising horse. J. Equine Vet. Sci. 2017, 52, 392. [Google Scholar] [CrossRef]
    Hulak, E.S.; Spooner, H.S.; Haffner, J.C. Influence of whole body vibration on bone density in the stalled horse. J. Equine Vet. Sci. 2017, 52, 393. [Google Scholar] [CrossRef]
    Memon, M.A.; Sprunger, L.K. Survey of colleges and schools of veterinary medicine regarding education in complementary and alternative veterinary medicine. J. Am. Vet. Med. Assoc. 2011, 239, 619–623. [Google Scholar] [CrossRef] [PubMed]
    Eisenberg, D.M.; Kessler, R.C.; Van Rompay, M.L.; Kaptchuk, T.J.; Wilkey, S.A.; Appel, S.; Davis, R.B. Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey. Ann. Intern. Med. 2001, 135, 344–351. [Google Scholar] [CrossRef] [PubMed]
    Chan, W.-W.; Chen, K.-Y.; Liu, H.; Wu, L.-S.; Lin, J.-H. Acupuncture for general veterinary practice. J. Vet. Med. Sci. 2001, 63, 1057–1062. [Google Scholar] [CrossRef] [PubMed][Green Version]
    Knight, N. The Behaviours and Attitudes Surrounding the use of Equine Complementary and Alternative Medicine Amongst Horse-Carers in the Auckland Region; Unitec Institute of Technology: Auckland, New Zealand, 2011; Available online: https://unitec.researchbank.ac.nz/handle/10652/1917 (accessed on 11 August 2021).
    Cerciello, S.; Rossi, S.; Visonà, E.; Corona, K.; Oliva, F. Clinical applications of vibration therapy in orthopaedic practice. Muscles Ligaments Tendons J. 2016, 19, 147–156. [Google Scholar] [CrossRef]

   
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style

Bergh, A.; Lund, I.; Boström, A.; Hyytiäinen, H.; Asplund, K. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals 2021, 11, 3356. https://doi.org/10.3390/ani11123356
AMA Style

Bergh A, Lund I, Boström A, Hyytiäinen H, Asplund K. A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”. Animals. 2021; 11(12):3356. https://doi.org/10.3390/ani11123356
Chicago/Turabian Style

Bergh, Anna, Iréne Lund, Anna Boström, Heli Hyytiäinen, and Kjell Asplund. 2021. "A Systematic Review of Complementary and Alternative Veterinary Medicine: “Miscellaneous Therapies”" Animals 11, no. 12: 3356. https://doi.org/10.3390/ani11123356
Find Other Styles
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
Article Metrics
Citations
Crossref
 
6
Web of Science
 
6
Scopus
 
6
Google Scholar
 
[click to view]
Article Access Statistics
Article access statisticsArticle Views15. Nov16. Nov17. Nov18. Nov19. Nov20. Nov21. Nov22. Nov23. Nov24. Nov25. Nov26. Nov27. Nov28. Nov29. Nov30. Nov1. Dec2. Dec3. Dec4. Dec5. Dec6. Dec7. Dec8. Dec9. Dec10. Dec11. Dec12. Dec13. Dec14. Dec15. Dec16. Dec17. Dec18. Dec19. Dec20. Dec21. Dec22. Dec23. Dec24. Dec25. Dec26. Dec27. Dec28. Dec29. Dec30. Dec31. Dec1. Jan2. Jan3. Jan4. Jan5. Jan6. Jan7. Jan8. Jan9. Jan10. Jan11. Jan12. Jan13. Jan14. Jan15. Jan16. Jan17. Jan18. Jan19. Jan20. Jan21. Jan22. Jan23. Jan24. Jan25. Jan26. Jan27. Jan28. Jan29. Jan30. Jan31. Jan1. Feb2. Feb3. Feb4. Feb5. Feb6. Feb7. Feb8. Feb9. Feb10. Feb11. Feb12. Feb0k1k2k3k4k5k
For more information on the journal statistics, click here.
Multiple requests from the same IP address are counted as one view.
Animals, EISSN 2076-2615, Published by MDPI RSS Content Alert
[*/quote*]
Logged
Stoppt die deutschen Massenmörder!
Stoppt die österreichischen Massenmörder!
Stoppt die schweizer Massenmörder!

Revolution jetzt. Sonst ist es zu spät.
Pages: [1]